StockData
Longeveron Inc. logo

Longeveron Inc. (LGVN) stock

LGVNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 5/30
$1.92−0.19 (-9.00%)

Close on Nov 18, 2026Market cap $61.21MP/E –Yield –

Longeveron EPS

Diluted earnings per share is net income divided by the share count including options and convertible securities.

Longeveron's EPS for the twelve months ending Jun 30, 2026 was -$0.77. For fiscal 2025 it was -$1.29. The highest annual figure on record is -$1.29 in fiscal 2025.

Annual eps

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$1.29–
FY2024Dec 31, 2024-$2.62–
FY2023Dec 31, 2023-$10.22–
FY2022Dec 31, 2022-$9.00–
FY2021Dec 31, 2021-$9.00–
FY2020Dec 31, 2020-$2.30–

Quarterly eps

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$0.19–
Q1 FY2026Mar 31, 2026-$0.19–
Q4 FY2025Dec 31, 2025$0.00–
Q3 FY2025Sep 30, 2025-$0.39–
Q2 FY2025Jun 30, 2025-$0.33–
Q1 FY2025Mar 31, 2025-$0.34–
Q3 FY2024Sep 30, 2024-$0.34–
Q2 FY2024Jun 30, 2024-$1.83–
Q1 FY2024Mar 31, 2024-$1.61–
Q3 FY2023Sep 30, 2023-$2.79–
Q2 FY2023Jun 30, 2023-$2.67–
Q1 FY2023Mar 31, 2023-$2.21–
Q2 FY2022Jun 30, 2022-$2.70–
Q1 FY2022Mar 31, 2022-$1.70–
Q4 FY2021Dec 31, 2021-$2.03–
Q3 FY2021Sep 30, 2021-$2.50–
Q2 FY2021Jun 30, 2021-$2.60–
Q1 FY2021Mar 31, 2021-$1.80–
Q4 FY2020Dec 31, 2020-$0.85–
Q3 FY2020Sep 30, 2020-$0.60–
Q2 FY2020Jun 30, 2020-$0.80–

More Longeveron figures

See a number that looks wrong?